Article Text

Download PDFPDF
A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine
  1. Ingrida Platais1,
  2. Tamar Tsereteli1,
  3. Galyna Maystruk2,
  4. Dilfuza Kurbanbekova3,
  5. Beverly Winikoff1
  1. 1 Gynuity Health Projects, New York City, New York, USA
  2. 2 Woman Health & Family Planning Charity Foundation, Kiev, Ukraine
  3. 3 Women’s Wellness Center, Tashkent, Uzbekistan
  1. Correspondence to Ingrida Platais, Gynuity Health Projects, New York City, NY 10017, USA; iplatais{at}gynuity.org

Footnotes

  • Contributors IP, TT and BW contributed to study design. IP, TT, GM and DK implemented the study and oversaw data collection. IP and TT led the analysis and writing of the manuscript with input from all authors.

  • Funding Financial support for this study was provided by an anonymous donor without financial interests in the outcome of this study.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The study was approved by the institutional review board at each study facility in Ukraine and by the ethical review board at the Ministry of Health of the Republic of Uzbekistan.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon reasonable request.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors IP, TT and BW contributed to study design. IP, TT, GM and DK implemented the study and oversaw data collection. IP and TT led the analysis and writing of the manuscript with input from all authors.

  • Funding Financial support for this study was provided by an anonymous donor without financial interests in the outcome of this study.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The study was approved by the institutional review board at each study facility in Ukraine and by the ethical review board at the Ministry of Health of the Republic of Uzbekistan.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.